Chemotherapy in Metastatic Nonanaplastic Thyroid Cancer: Experience at the Institut Gustave-Roussy-Reference-Cited by-同舟云学术

Chemotherapy in Metastatic Nonanaplastic Thyroid Cancer: Experience at the Institut Gustave-Roussy

Published:1990-10 Issue:5 Volume:76 Page:480-483
ISSN:0300-8916
Container-title:Tumori Journal
language:en
Short-container-title:Tumori

Author:

Droz Jean-Pierre¹,Schlumberger Martin²,Rougier Philippe¹,Ghosn Marwane¹,Gardet Paule²,Parmentier Claude²

Affiliation:

1. From the Department of Medicine, Institut Gustave-Roussy, Villejuif, France

2. Department of Radiation, Institut Gustave-Roussy, Villejuif, France

Abstract

Forty-nine patients with metastatic nonanaplastic thyroid carcinoma were treated over a 10-year period. Five successive chemotherapeutic protocols were used: a combination of doxorubicin, etoposide, 5-fluorouracil and cyclophosphamide; elliptinium acetate; doxorubicin; cispiatin; and the combination of doxorubicin and cispiatin. Results obtained with the different protocols were very disappointing, with only two objective responses (3%). Phase II trials with new chemotherapeutic agents are warranted in selected cases of nonanaplastic metastatic thyroid carcinoma.

Publisher

SAGE Publications

Subject

Cancer Research,Oncology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/030089169007600513

Reference26 articles.

1. Combination chemotherapy of metastatic thyroid cancer

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine Kinase Inhibitors for Radioactive Iodine Refractory Differentiated Thyroid Cancer;Life;2023-12-22

2. Cabozantinib for different endocrine tumours: killing two birds with one stone. A systematic review of the literature;Endocrine;2023-10-18

3. Disease-Specific Survival Trends for Patients Presenting with Differentiated Thyroid Cancer and Distant Metastases in the United States, 1992–2018;Thyroid;2023-01-01

4. Systemic Therapy in Thyroid Cancer;Thyroid Cancer - The Road From Genes to Successful Treatment [Working Title];2022-11-09

5. Efficacy and safety of targeted therapeutics for patients with radioiodine-refractory differentiated thyroid cancer: Systematic review and network meta-analysis;Frontiers in Pharmacology;2022-08-26